Chapter 30 Pathogenesis of Serous Detachment of the Retina and Pigment Epithelium
Retinal detachment is defined as the accumulation of fluid between the neurosensory retina (NSR) and the underlying retinal pigment epithelium (RPE) in the remnant of the embryonic optic vesicle. Retinal pigment epithelial detachment (PED) results from a separation between the RPE basement membrane and the inner collagenous layer of Bruch’s membrane.1,2 These abnormalities imply a dysfunction of the RPE that may be caused by choroidal or retinal diseases or both.
Anatomic constituents
Blood–retinal barrier
The blood–retinal barrier (BRB) is a particularly restrictive physiological barrier that regulates the flow of nutrients, metabolic waste products, ions, proteins, and water flux into and out of the retina. The main component is the RPE, a single polarized monolayer of cells that forms the outer BRB (the inner BRB being formed of tight junctions between retinal capillary endothelial cells). The outer BRB is located at the tight junctions between the apical lateral membranes of the RPE cells. Its integrity is fundamentally important for the health and integrity of the inner retina.3
Mechanism of normal attachment
The RPE plays a critical role in the visual cycle and photoreceptor outer-segment phagocytosis. Futhermore, it is the main transport pathway between the inner retina and the choriocapillaris.5 The mechanisms by which the retina is normally maintained in apposition to the pigment epithelium, and the pigment epithelium to Bruch’s membrane, have not been defined, although many factors have been identified. Mechanical and metabolic factors intervene in the attachment from the RPE to the photoreceptors on one side and to Bruch’s membrane on the other side.
Mechanical factors
The physiological mechanisms of adhesion of the neural retina to the RPE are highly synergistic and complex and involve mechanical and metabolic factors.6 Briefly, these include the active and passive metabolism of the RPE, the properties of the interphotoreceptor matrix (IPM), and established pressure gradients between the retina and choroid.
Adhesion
Mechanical forces inside the subretinal space (SRS) include the matrix material between the NSR and RPE and the complex anatomical relationship with the outer segments of the photoreceptors.7
The IPM occupies the interface between the photoreceptor outer segments. It is composed of glycoproteins, proteoglycans, and glycosaminoglycans.8 This matrix may act as a glue binding the NSR and the RPE. Cones and rods are surrounded by a specialized matrix.9 The IPM also has structural components that remain attached to both the RPE and the cones and become apparent when the RPE is peeled off.10,11
Cell adhesion molecules or receptors may be involved in this interaction between the matrix and the cellular membranes.12 Factors that affect the physicochemical properties of the IPM and enzymes that degrade some of its components such as proteoglycan-degrading enzymes (given intravitreally or directly into the IPM in primate eyes) weaken retinal adhesion.13 Similarly, hyaluronidase and neuraminidase degrade chondroitin sulfate proteoglycan and sialoglycoconjugates, respectively. This decreased adhesion suggests that the IPM plays a role in normal retina–RPE adhesion.14
The mechanism by which interdigitations of RPE apical villous processes and photoreceptor outer segments contribute to retinal adhesion is not yet clear. They play a crucial role in disc phagocytosis and renewal, but their role in adhesion is uncertain.15 They may provide a frictional resistance or an electrostatic force that opposes separation, but the magnitude of this is unknown.15 However, three mechanisms have been proposed. These include the continuous process of phagocytosis of photoreceptor outer segments by RPE cells during which the two cells are intimately connected,16 the frictional forces that result from the interdigitations and the possible presence of electrostatic interaction between the cell membranes.17
Pressure gradient
Formed vitreous acts in maintaining adhesion between the retina and RPE.18 Whether the vitreous plays a direct role in retinal adhesion is yet to be determined, although some studies suggest the physical structure of the vitreous might be of importance in maintaining retinal apposition.18,19
Metabolic factors
Metabolic factors that affect retinal adhesion are intricate.
Oxygenation
Retinal adhesion is markedly decreased after death20,21 and is restored with oxygenation.22 This can either be due to the effect of released RPE lysosomal enzymes on IPM23 or due to the effect of ischemia on active RPE fluid transport.24 The importance of metabolic factors in retinal adhesion is also inferred from the effect of many drugs that interfere with the pH and RPE fluid transport activity.
Water movement
The RPE actively transports water from the SRS to the choroid. This active transport, as well as dehydrating the SRS, is a crucial factor in maintaining adhesion. RPE fluid transport is normally limited by the retina, which resists water flow from the vitreous. Fluid exits the eye through the trabecular meshwork; however, a small proportion tends to exit from the vitreous to the choroid by virtue of the intraocular and choroidal oncotic pressures.25
In addition, the high osmotic pressure in the choroid causes outward movement of water.26–28 Also, the RPE is constantly moving ions toward the choroid with the associated movement of water.29
An inward movement of fluid from the choroid into the vitreous could lead to retinal separation from the RPE because of retinal resistance to flow.30,31
Mechanisms of impairment
Impairment of water movement
The retina will stay attached whether or not the RPE is intact, but retinal function requires the RPE barrier. Clinical serous detachments are unlikely to form solely as a result of small RPE defects or leaks, since the active and passive transport systems for removing subretinal fluid are both strong. The primary pathology in most cases of serous retinopathy is a diffuse metabolic or vascular abnormality of RPE fluid transport, and RPE defects or leaks are necessary, but only secondary, components of the disease.32
The development of a retinal PED is related to disorders in fluid outflow between the sensory retina and Bruch’s membrane.33 The normal nonvascular nature of Bruch’s membrane is due to suppression by RPE of inward growth of choroidal blood vessels. This change occurs in response to aging. The stimulus to change in growth factor production by RPE is unknown, but it is surmised that it may be due to lack of metabolic supply from plasma as a result of reduced diffusion of material through the thickened Bruch’s membrane, or from reduced oxygen supply consequent upon changes in the choroidal capillaries.34
The pathogenetic theory is that of reduced hydraulic conductivity of Bruch’s membrane. The mechanisms underlying this process are attributed to increased deposition of lipids, enhanced collagen crosslinking, and alteration in the ratio of tissue-dissolving enzymes and their inhibitors. Detachment of the RPE is likely to be the consequence of increased resistance of Bruch’s membrane to water flow due to deposition of lipids.35
Occurrence of detachment
A serous detachment will form if there are conditions that drive fluid against the normal gradients into the SRS and that limit its subsequent removal by active and passive transport. As long as the RPE is able to pump the leaking fluid into the choroidal circulation, no fluid accumulates in the SRS and no retinal detachment occurs. However, if the process continues and the normal RPE pump activity becomes overwhelmed, or if the RPE activity decreases because of RPE loss or decreased metabolic supply (e.g., ischemia), then fluid starts to accumulate and a retinal detachment occurs.36 This type of retinal detachment can be also due to accumulation of blood in the SRS (hemorrhagic retinal detachment).
IFN-γ receptors localized to the basolateral membrane of human RPE inhibit, when activated, cell proliferation and migration, decrease RPE mitochondrial membrane potential, alter transepithelial potential and resistance, but also significantly increase transepithelial fluid absorption. In vivo experiments showed that IFN-γ can remove extra fluid deposited in the extracellular or SRS between the retinal photoreceptors and RPE.5 Removal of this extra fluid can be blocked by a combination of inhibitors injected into the SRS. In addition, the IFN-CFTR pathway in RPE is activated by nitric oxide, which is continually produced in large amounts by the inner retina and, perhaps, by the choriocapillaris. IFN-γ regulates retinal hydration across the outer BRB, helps dehydrate the SRS, and maintains a close anatomical relationship between the photoreceptors and RPE.37
Persistence and resorption of serous detachments
When the retina separates from the RPE secondary to retinal detachment of any type, the outer retina becomes ischemic due to loss of its blood supply from the choroid. Photoreceptor cell degeneration has been shown to increase as the distance between the RPE layer and the photoreceptor layer increases. The earliest light microscopic manifestations include accumulation of subretinal fluid with loss of photoreceptor outer segments, and if the process persists, the entire photoreceptor cell layer becomes atrophic.38–40
Apoptosis appears to play an important role in the time-dependent photoreceptor cell degeneration that occurs following retinal detachment.41 In cases of chronic detachment, more prominent changes occur, including cystic and macrocystic retinal degeneration, retinal thinning, RPE alterations, demarcation lines, large drusen, choroidal neovascularization (CNV) at the ora serrata, and iris neovascularization secondary to angiogenic factor elaboration by the ischemic detached retina. As the detachment is mostly centered on the macula, the foveal cones at a distance from the RPE are less likely to receive adequate oxygenation and other nutrients from the choriocapillaris. After retinal reattachment, photoreceptor atrophy in the fovea typically occurs after a long duration.42
Subretinal fluid is removed both by active transport across the RPE and by passive hydrostatic and oncotic forces that work most effectively when the RPE barrier has been damaged. Saline subretinal fluid is removed across the RPE into the choroidal space primarily by RPE metabolic activity.43 cGMP, acetazolamide, and hyperosmotic agents experimentally facilitate its resorption. Clinical retinal detachments invariably contain protein, which slows the absorption of fluid. The biochemical interplay between the RPE and the retinal photoreceptors is affected.43
Potential sources of variation in the dynamics of precipitation and resorption of subretinal lipid include the surface area of the source of leakage and its effective pore size, the surface area of the site(s) of resorption, the active fluid and salt resorption capacity of the RPE, the phagocytic activity of the RPE and infiltrating macrophages, and the degree of infiltration of phagocytic cells in the SRS.44
The effects of intraocular pressure, vitreous pressure, and gravity on the resorption of small experimental retinal detachments (blebs) made with Hanks’ solution or autologous serum was shown to be limited to normal subretinal fluid absorption. Neither liquefaction of the vitreous nor retinal weight has a significant influence on fluid absorption.45
Clinical manifestations of PED and serous retinal detachments
The source of the fluid is the vessels of the choroid, or the retina, or both. This can occur in a variety of vascular, inflammatory, or neoplastic diseases of the retina, RPE, and choroid46 in which fluid leaks outside the vessels and accumulates under the retina. It is suggested that the primary pathology in most serous retinopathy is a diffuse metabolic or vascular abnormality of RPE fluid transport, and that RPE defects or leaks are necessary but only secondary components of the disease.
Serous retinal detachment associated with choroidal dysregulation
Central serous chorioretinopathy
The separation of the outer segments of photoreceptors from the RPE by subretinal fluid should slow down the exchange of all-trans and 11-cis retinal. The RPE–photoreceptor visual cycle serves mainly the rods, and cone function is supported by a separate visual cycle within the sensory retina,47 and is thus less affected by the separation from the RPE.
Central serous chorioretinopathy (CSC) is a disease in which the NSR becomes detached, supposedly due to a single or multiple focal lesions within the RPE, which leaks into the SRS overlying dysregulation of the choroidal vasculature. With indocyanine green angiography (ICGA), it has been demonstrated that CSC primarily affects the choroidal circulation and causes multifocal areas of choroidal vascular hyperpermeability.48,49 PED shown by biomicroscopy, fluorescein angiography (FA), ICGA, and optical coherence tomography (OCT) can be seen in early stages of CSC, under the SRD. The location of these PEDs is the same as the location of the leakage in FA. Spontaneous resolution is the usual outcome.50 The serous detachment extends significantly beyond the leak if the tight junctional RPE barrier under the elevated retina (except directly over the areas of leakage) is intact, since fluid would otherwise leave under hydrostatic and osmotic pressure.51
Chronic forms of CSC, defined as a persistent choroidal anomaly demonstrated on ICGA, are not the rule. In those cases, PEDs do not always accompany an SRD.52 ICGA has demonstrated the presence of “multiple presumed occult” PEDs in both acute and chronic stages.53
There are multiple theories on the origin of CSC, none of which has been completely demonstrated. Neither RPE nor choroidal dysfunction can be effectively pointed out as the sole causative mechanism. The leakage rate corresponds to bulk fluid flow, rather than secretion and diffusion,54 which indicates that the underlying choroid is possibly responsible and not the RPE. Focal areas of hyperpermeability visualized as tiny punctuate spots in the inner choroid may be involved in the development of SRD.55 During the period of time in which the retina remains detached, many events occur which have to do with the change in metabolism and intercellular processes. The outer segments of photoreceptors overlying the detached area are no longer phagocytosed, the photoreceptors elongate,56 and finally, outer segments begin to accumulate, resulting in the deposit of multiple dot-like yellow precipitates and material. This material is demonstrated by high reflectivity on OCT and hyperautofluorescence.57 The autofluorescent fluorophores in the photoreceptor outer segments may be concentrated in precipitates or settled into the inferior SRD.58 These could correspond to the recently described acute hypertrophic outer retinal changes.59
The structure of the detached NSR in eyes with CSC remains preserved.60 Photoreceptor apoptosis has been postulated as implicated in visual function in CSC, since apoptosis has been reported in experimental retinal detachment and human retinal detachment within a few days.61
Upon resolution the fluid will be reabsorbed rapidly for water and ions, whereas macromolecules will remain in the SRS and precipitate. After a long resolved episode, a hyperautofluorescent aspect remains on retinal imaging.62
The high protein content of serous detachments, which is caused by oncotic pressure, has been put forward as an explanation for why subretinal fluid forms and persists in CSC. It is this continued influx, and the presence of a reduced absorptive capacity of the surrounding RPE, that maintains the detachment. Protein entering the SRS can be sequestered and concentrated by fluid absorption, but it does not directly cause or maintain the detachment. Although fluid absorption across the RPE is compromised, the underlying pathology appears often to be choroidal vascular disease.63
Serous retinal detachment in idiopathic polypoidal choroidal vasculopathy
Idiopathic polypoidal choroidal vasculopathy (PCV) is a distinct exudative disorder in which the SRD is thought to be of choroidal origin.64 PCV is a disease in which the primary abnormality involves the inner choroidal circulation, where thin capillary vessels dilate within Bruch’s membrane, immediately under the RPE, where they form cavernous vascular channels.65 It is distinguishable from more typical proliferations of abnormal choroidal vessels.66
PCV is caused by inner choroidal vessel abnormalities, not CNV.67 These lesions cause serosanguineous RPE detachments via damage to the overlying Bruch’s membrane and/or RPE The histopathological findings suggest that these lesions can be more accurately considered as a degenerated RPE–Bruch’s membrane–choriocapillaris complex and inner choroid dilated venules and arterioles, rather than an intra-Bruch’s fibrovascular membrane.68 Both CNV and vascular polyps have been identifed as hyperreflectivity between RPE and Bruch’s membrane, in the same tissue plane as CNV.69 It has been suggested that the underlying mechanism in these lesions is related to atherosclerosis.70
The juxtaperipapillary lesions resemble small serous PEDs on biomicroscopy, and are visible on ICGA as hyperfluorescent nodules in early phases with a “washout” effect on very late phases.71 Multifocal choroidal hyperfluorescence might be one of the risk factors of PCV.70 These PEDs regress incompletely and may recur despite treatment with photodynamic therapy or bevacizumab.71 About one-third of patients have PCV lesions that resemble CNV both clinically and angiographically.
Serous retinal detachment in uveitis: exudative retinal detachment
Later, when more inflammatory damage develops and/or fluid volume increases, retinal resistance may become insufficient, and the fluid may enter the neuroretinal tissue and form cysts. The transient aspect of a subfoveal SRD in uveitis and favorable response to treatment support this hypothesis. A subfoveal SRD may also be documented in patients with normal neuroretinal tissue and without edema.72
In the acute phase of Vogt–Koyanagi–Harada disease, fluorescein angiography has shown increased permeability of the chorioretinal vessels and of the BRB, and delayed circulation of the choriocapillaris.73,74
NSR serous detachment of the macula resulting from focal retinochoroiditis has been reported previously in patients with Bartonella-associated neuroretinitis. SRD may precede the formation of a macular star in a minority of patients with neuroretinitis.75 The macular exudates may take months to resolve.76
Detachment of retinal origin
Serous retinal detachment in diabetic retinopathy
Diabetic macular edema (DME) is thought to be caused by hyperpermeability in the retinal vasculature, leading to dysfunction of the neuroglial cells and concomitant visual disturbance. Macular SRD occurs in 15–30% of patients with diabetic maculopathy.77,78 SRD in DME is diagnosed on OCT even when the neuroretinal tissue above the SRD is normal.79 Retinal functionality in these types of SRD is controversial.80 It has been reported that macular SRD in diabetic patients is more often correlated with high levels of HbA1c, and that this might break both the inner and the outer BRB.81
Transient SRD may represent a step in the process of macular edema absorption. Its evolution is not related to the severity of DME, and it sometimes disappears before resorption of retinal fluid. The elongation of the photoreceptors is not visualized in diabetic retinopathy-associated SRD, suggesting that the pathogenesis of this disease might be different.82 The high protein content of the fluid in these SRDs could alter the oxygenation and elimination of metabolites from the photoreceptor layer, thus decreasing retinal sensibility.
The involvement of the RPE is also thought to play a role in the hydrodynamics of fluid accumulation into the SRS, where hypoxia might impede its normal pump function. RPE impairment has already been proven in human and experimental diabetes.83 Thus SRD in diabetic maculopathy is linked not only to the limited drainage of the vascular system (both retinal and choroidal) but also to impairment in the function of the RPE.
Severe retinal detachment in central or branch retinal vein occlusion
Severe retinal vein occlusion may be accompanied by extensive SRD.84 SRD can be demonstrated in approximately 80% of central retinal vein occlusion patients with cystoid macular edema.85 It appears that SRD is more frequent in major branch retinal vein occlusion (BRVO) than in macular BRVO.86 In cases of major BRVO, a positive correlation with vascular endothelial growth factor and the presence of SRD has been reported.87 The major complication of serous detachment is the deposit of macular hard exudates, which may result in poor visual outcome.88
Other causes
A large number of diseases, both ocular and systemic, have been associated with SRD. Different immunogammopathies have also have been associated with serous macular detachments: multiple myeloma, Waldenström’s macroglobulinemia, and immunoglobulin M paraproteinemia. Acute leukemias have been described while on chemotherapy or during a relapse.89 The mechanism of SRD in hypertensive choroidopathy as well as in eclampsia is more linked to renal failure and subsequent uremia.90
Choroidal effusion syndrome is thought to be due to the compression of the vortex veins by a rigid sclera, impeding the normal outflow of fluid within the choriocapillaris. Choroidal melanomas and retinoblastoma have been associated with SRD.91 Vascular malformations such as retinal capillary hemangioma, phacomatoses, and carotid-cavernous fistula have all been associated with SRD.
1 Murphy RP, Yeo JH, Green WR, et al. Dehiscences of the pigment epithelium. Trans Am Ophthalmol Soc. 1985;83:63–81.
2 Green WR, McDonnell PJ, Yeo JH. Pathologic features of senile macular degeneration. Ophthalmology. 1985;92:615–621.
3 Cunha-Vaz J, Bernardes R, Lobo C. Blood–retinal barrier. Eur J Ophthalmol. 2010;21:3–9.
4 Anand-Apte B, Hollyfield JG. Developmental anatomy of the retinal and choroidal vasculature. Cleveland, OH: Elsevier; 2010.
5 Li R, Maminishkis A, Banzon T, et al. IFNγ regulates retinal pigment epithelial fluid transport. IFNγ regulates retinal pigment epithelial fluid transport. Am J Physiol Cell Physiol. 2009;297:C1452–C1465.
6 Marmor MF. Mechanisms of retinal adhesion. In: Ryan SJ, ed. Retina. Los Angeles, CA: Elsevier; 2006:1891–1908.
7 Campochiaro PA, Jerdon JA, Glaser BM. The extracellular matrix of human retinal pigment epithelial cells in vivo and its synthesis in vitro. Invest Ophthalmol Vis Sci. 1986;27:1615–1621.
8 Porrello K, LaVail MM. Histochemical demonstration of spatial heterogeneity in the interphotoreceptor matrix of the rat retina. Invest Ophthalmol Vis Sci. 1986;27:1577–1586.
9 Hollyfield JG, Varner HH, Rayborn ME, et al. Retinal attachment to the pigment epithelium. Linkage through an extracellular sheath surrounding cone photoreceptors. Retina. 1989;9:59–68.
10 Hageman GS, Marmor MF, Yao XY, et al. The interphotoreceptor matrix mediates primate retinal adhesion. Arch Ophthalmol. 1995;113:655–660.
11 Johnson LV, Hageman GS. Characterization of molecules bound by the cone photoreceptor-specific monoclonal antibody CSA-1. Invest Ophthalmol Vis Sci. 1988;29:550–557.
12 Opas M, Kalnins VI. Distribution of spectrin and lectin binding materials in surface lamina of RPE cells. Invest Ophthalmol Vis Sci. 1985;26:621–627.
13 Yao XY, Hageman GS, Marmor MF. Retinal adhesiveness is weakened by enzymatic modification of the interphotoreceptor matrix in vivo. Invest Ophthalmol Vis Sci. 1990;31:2051–2058.
14 Yoon YH, Marmor MF. Effects of retinal adhesion of temperature, cyclic AMP, cytochalasin, and enzymes. Invest Ophthalmol Vis Sci. 1988;29:910–914.
15 Fisher SK, Lewis GP. Cellular effects of detachment and reattachment on the neural retina and retinal pigment epithelium. In: Ryan SJ, ed. Retina. Los Angeles, CA: Elsevier; 2006:1991–2012.
16 Marmor MF. Mechanisms of normal retinal adhesion. In: Ryan SJ, Wilkinson CP. Retina. St Louis: Mosby; 2001:1849–1869.
17 Gingell D, Fornes JA. Demonstration of intermolecular forces in cell adhesion using a new electrochemical technique. Nature. 1975;256:210–211.
18 Foulds WS. The vitreous in retinal detachment. Trans Ophthalmol Soc UK. 1975;95:412–416.
19 Osterlin S. On the molecular biology of the vitreous in the phakic eye. Acta Ophthalmol. 1977;55:353–361.
20 Yao XY, Hageman GS, Marmor MF. Retinal adhesiveness in the monkey. Invest Ophthalmol Vis Sci. 1994;35:744–748.
21 Marmor MF, Yao XY. The metabolic dependency of retinal adhesion in rabbit and primate. Arch Ophthalmol. 1995;113:232–238.
22 Kim R, Yao XY, Marmor MF. Oxygen dependency of retinal adhesion. Invest Ophthalmol Vis Sci. 1993;34:2074–2078.
23 Kain HL, Libondi T. Experimentelle Netzhautablosung-untersuchungen zum Pathomechanismus. Fortschr Ophthalmol. 1986;83:590–596.
24 Marmor MF. Mechanisms of retinal adhesion. In: Ryan SJ, ed. Retina. Los Angeles, CA: Elsevier; 2006:1891–1908.
25 Orr G, Goodnight R, Lean JS. Relative permeability of retina and retinal pigment epithelium to the diffusion of tritiated water from vitreous to choroid. Arch Ophthalmol. 1986;104:1678–1680.
26 Casswell AG, Gregor ZJ, Bird AC. The surgical management of uveal effusion syndrome. Eye (Lond). 1987;1:115–119.
27 Machemer R. The importance of fluid absorption, traction, intraocular currents, and chorioretinal scars in the therapy of rhegmatogenous retinal detachments. Am J Ophthalmol. 1984;98:681–693.
28 Negi A, Marmor MF. Experimental serous retinal detachment and focal pigment epithelial damage. Arch Ophthalmol. 1984;102:445–449.
29 Van Buskirk EM, Lessell S, Friedman E. Pigmentary epitheliopathy and erythema nodosum. Arch Ophthalmol. 1971;85:369–372.
30 Marmor MF. Retinal detachment from hyperosmotic intravitreal injection. Invest Ophthalmol Vis Sci. 1979;18:1237–1244.
31 Marmor MF, Martin LJ, Tharpe S. Osmotically induced retinal detachment in the rabbit and primate. Invest Ophthalmol Vis Sci. 1980;19:1016–1029.
32 Marmor MF. Control of subretinal fluid: experimental and clinical studies. Eye (Lond). 1990;4:340–344.
33 Bird AC, Marshall J. Retinal pigment epithelial detachments in the elderly. Trans Ophthalmol Soc UK. 1986;105:614–668.
34 Holtz FG, Sheraidah G Pauleikhoff D, et al. Analysis of lipid deposits extracted from human macular and peripheral Bruch’s membrane. Arch Ophthalmol. 1994;112:402–406.
35 Curcio C, Baily T, Knuth HS, et al. Accumulation of cholesterol with age in human Bruch’s membrane. Invest Ophthalmol Vis Sci. 2001;42:265–274.
36 Marmor MF. New hypothesis on the pathogenesis and treatment of serous retinal detachment. Graefe’s Arch Clin Exp Ophthalmol. 1988;226:548–552.
37 Marmor MF. Control of subretinal fluid: experimental and clinical studies. Eye (Lond). 1990;4:340–344.
38 Green WR. Retina. Ophthalmic pathology: an atlas and textbook. 4th ed. Spencer WH, ed. Ophthalmic pathology: an atlas and textbook. Philadelphia: WB Saunders; 1996;Vol 2:667–1313.
39 Yamana T, Kita M, Ozaki S, et al. The process of closure of experimental retinal holes in rabbit eyes. Graefe’s Arch Clin Exp Ophthalmol. 2000;238:81–87.
40 Guerin CJ, Anderson DH, Fariss RN, et al. Retinal reattachment of the primate macula. Photoreceptor recovery after short-term detachment. Invest Ophthalmol Vis Sci. 1989;30:1708–1725.
41 Arroyo JG, Yang L, Bula D, et al. Photoreceptor apoptosis in human retinal detachment. Am J Ophthalmol. 2005;139:605–610.
42 Gemenetzi M, De Salvo G, Lotery AJ. Central serous retinopathy: an update on pathogenesis and treatment. Eye (Lond). 2010;24:1743–1756.
43 Kawano S, Marmor MF. Metabolic influences on the absorption of serous subretinal fluid. Invest Ophthalmol Vis Sci. 1988;29:1255–1257.
44 Taarnhoj NC, Kjeka O, Larsen M. Kinetics of retinal lipoprotein precipitation and elimination after closure of subretinal new vessels. Invest Ophthalmol Vis Sci. 2003;44:1680–1685.
45 Negi A, Kawano S-I, Marmor MF. Effects of intraocular pressure and other factors on subretinal fluid resorption. Invest Ophthalmol Vis Sci. 1987;28:2099–2102.
46 Anand R, Tasman WS. Nonrhegmatogenous retinal detachment. Retina. 3rd ed. Ryan SJ, Wilkinson CP, eds. Retina. St Louis: Mosby; 2001;Vol 3:2076–2099.
47 Rando RR, Bangerter FW. The rapid intermembraneous transfer of retinoids. Biochem Biophys Res Commun. 1982;104:430.
48 Piccolino FC, Borgia L. Central serous chorioretinopathy and indocyanine green angiography. Retina. 1994;14:231–242.
49 Lai TY, Chan WM, Li H, et al. Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study. Br J Ophthalmol. 2006;90:869–874.
50 Gass JDM. Stereoscopic atlas of macular diseases: diagnosis and treatment. St Louis: Mosby; 1997. p. 49–70
51 Marmor MF. New hypothesis on the pathogenesis and treatment of serous retinal detachment. Graefes Arch Clin Exp Ophthalmol. 1988;226:548–552.
52 van Velthoven ME, Verbraak FD, Garcia PM, et al. Evaluation of central serous retinopathy with en face optical coherence tomography. Br J Ophthalmol. 2005;89:1483–1488.
53 Guyer DR, Yannuzzi LA, Slakter JS, et al. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol. 1994;112:1057–1062.
54 Pryds A, Sander B, Larsen M. Characterization of subretinal fluid leakage in central serous chorioretinopathy. Invest Ophthalmol Vis Sci. 2010;51:5853–5857.
55 Tsujikawa A, Ojima Y, Yamashiro K, et al. Punctate hyperfluorescent spots associated with central serous chorioretinopathy as seen on indocyanine green angiography. Retina. 2010;30:801–809.
56 Matsumoto H, Kishi S, Otani T, et al. Elongation of photoreceptor outer segment in central serous chorioretinopathy. Am J Ophthalmol. 2008;145:162–168.
57 Maruko I, Iida T, Ojima A, et al. Subretinal dot-like precipitates and yellow material in central serous chorioretinopathy. Retina. 2011;4:759–765.
58 Matsumoto H, Kishi S, Sato T, et al. Fundus autofluorescence of elongated photoreceptor outer segments in central serous chorioretinopathy. Am J Ophthalmol. 2011;151:617–623.
59 Cho M, Athanikar A, Paccione J, et al. Optical coherence tomography features of acute central serous chorioretinopathy versus neovascular age-related macular degeneration. Br J Ophthalmol. 2010;94:597–599.
60 Maruko I, Iida T, Sekiryu T, et al. Morphologic changes in the outer layer of the detached retina in rhegmatogenous retinal detachment and central serous chorioretinopathy. Am J Ophthalmol. 2009;147:489–494.
61 Ojima A, Iida T, Sekiryu T, et al. Photopigments in central serous chorioretinopathy. Am J Ophthalmol. 2011;151:940–952.
62 Ayata A, Tatlipinar S, Kar T, et al. Near-infrared and short-wavelength autofluorescence imaging in central serous chorioretinopathy. Br J Ophthalmol. 2009;93:79–82.
63 Marmor MF. On the cause of serous detachments and acute central serous chorioretinopathy. Br J Ophthalmol. 1997;81:812–813.
64 Yannuzzi LA, Sorenson J, Spaide RF, et al. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina. 1990;10:1–8.
65 Lafaut BA, Aisenbrey S, Van den Broecke C, et al. Polypoidal choroidal vasculopathy pattern in age-related macular degeneration: a clinicopathologic correlation. Retina. 2000;20:650–654.
66 Imamura Y, Engelbert M, Iida T, et al. Polypoidal choroidal vasculopathy: a review. Surv Ophthalmol. 2010;55:501–515.
67 Yuzawa M, Mori R, Kawamura A. The origins of polypoidal choroidal vasculopathy. Br J Ophthalmol. 2005;89:602–607.
68 Okubo A, Sameshima M, Uemura A, et al. Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study. Br J Ophthalmol. 2002;86:1093–1098.
69 Ojima Y, Hangai M, Sakamoto A, et al. Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography. Retina. 2009;29:52–59.
70 Sasahara M, Tsujikawa A, Musashi K, et al. Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability. Am J Ophthalmol. 2006;142:601–607.
71 Chae JB, Lee JY, Yang SJ, et al. Time-lag between subretinal fluid and pigment epithelial detachment reduction after polypoidal choroidal vasculopathy treatment. Korean J Ophthalmol. 2011;25:98–104.
72 Ossewaarde-van Norel J, Berg EM, Sijssens KM, et al. Subfoveal serous retinal detachment in patients with uveitic macular edema. Arch Ophthalmol. 2011;129:158–162.
73 Yamanaka E, Ohguro N, Yamamoto S, et al. Evaluation of pulse corticosteroid therapy for Vogt–Koyanagi–Harada disease assessed by optical coherence tomography. Am J Ophthalmol. 2002;134:454–456.
74 Ducos de Lahitte G, Terrada C, Tran TH, et al. Maculopathy in uveitis of juvenile idiopathic arthritis: an optical coherence tomography study. Br J Ophthalmol. 2008;92:64–69.
75 Pollock SC, Kristinsson J. Cat-scratch disease manifesting as unifocal helioid choroiditis. Arch Ophthalmol. 1998;116:1249–1251.
76 Kalogeropoulos C, Koumpoulis I, Mentis A, et al. Bartonella and intraocular inflammation: a series of cases and review of literature. Clin Ophthalmol. 2011;5:817–829.
77 Ozdemir H, Karacorlu M, Karacorlu S. Serous macular detachment in diabetic cystoid macular oedema. Acta Ophthalmol Scand. 2005;83:63–66.
78 Catier A, Tadayoni R, Paques M, et al. Characterization of macular edema from various etiologies by optical coherence tomography. Am J Ophthalmol. 2005;140:200–206.
79 Gaucher D, Sebah C, Erginay A, et al. Optical coherence tomography features during the evolution of serous retinal detachment in patients with diabetic macular edema. Am J Ophthalmol. 2008;145:289–296.
80 Deak GG, Bolz M, Ritter M, et al. A systematic correlation between morphology and functional alterations in diabetic macular edema. Invest Ophthalmol Vis Sci. 2010;51:6710–6714.
81 Turgut B, Gul FC, Ilhan N, et al. Comparison of serum glycosylated hemoglobin levels in patients with diabetic cystoid macular edema with and without serous macular detachment. Indian J Ophthalmol. 2010;58:381–384.
82 Murakami T, Nishijima K, Sakamoto A, et al. Association of pathomorphology, photoreceptor status, and retinal thickness with visual acuity in diabetic retinopathy. Am J Ophthalmol. 2011;151:310–317.
83 Kirber WM, Nichols CW, Grimes PA, et al. A permeability defect of the retinal pigment epithelium. Occurrence in early streptozocin diabetes. Arch Ophthalmol. 1980;98:725–728.
84 Tsujikawa A, Sakamoto A, Ota M, et al. Serous retinal detachment associated with retinal vein occlusion. Am J Ophthalmol. 2010;149:291–301.
85 Ozdemir H, Karacorlu M, Karacorlu S. Serous macular detachment in central retinal vein occlusion. Retina. 2005;25:561–563.
86 Yamaguchi Y, Otani T, Kishi S. Serous macular detachment in branch retinal vein occlusion. Retina. 2006;26:1029–1033.
87 Park SP, Ahn JK, Mun GH. Aqueous vascular endothelial growth factor levels are associated with serous macular detachment secondary to branch retinal vein occlusion. Retina. 2010;30:281–286.
88 Takahashi K, Kashima T, Kishi S. [Serous macular detachment combined with branch retinal vein occlusion.]. Nihon Ganka Gakkai Zasshi. 2005;109:362–367.
89 Dhar-Munshi S, Alton P, Ayliffe WH. Masquerade syndrome: T-cell prolymphocytic leukemia presenting as panuveitis. Am J Ophthalmol. 2001;132:275–277.
90 Gass JD. Bullous retinal detachment and multiple retinal pigment epithelial detachments in patients receiving hemodialysis. Graefes Arch Clin Exp Ophthalmol. 1992;230:454–458.
91 Muscat S, Parks S, Kemp E, et al. Secondary retinal changes associated with choroidal naevi and melanomas documented by optical coherence tomography. Br J Ophthalmol. 2004;88:120–124.